Table 1.
Characteristics of clients receiving PrEP at the Los Angeles LGBT Center, n=3,121 starting between January 1, 2014 and December 31, 2017
| Total | ||
|---|---|---|
| n | %g | |
| No. individuals | 3,121 | 100% |
| Person-years (mean/patient, range) | 3,246 (1.0, 0.0–4.0) | |
| Mean time to first discontinuation, person-years (SD, range) | 0.5 (0.5, 0.0–3.2) | |
| Status at end of follow-up | ||
| Current PrEP prescription | 1,314 | 42% |
| Discontinued PrEPa | 762 | 24% |
| Lost to follow-upb | 1,045 | 33% |
| Pattern of PrEP use | ||
| Continuous | 1,692 | 54% |
| Episodic | 1,429 | 46% |
| HIV rate (cases/100 person-years) | ||
| Current PrEP prescription at time of diagnosis | 0.1 (3/2,624) | |
| Discontinued PrEP before time of diagnosis | 2.1 (10/478) | |
| Days between last PrEP pill and HIV diagnosis, mean (SD, range) | 150 (130, 0–294) | |
| Age, mean (SD, range) | 33.3 (8.9, 18.1–75.8) | |
| Age | ||
| 18–24 | 445 | 14% |
| 25–30 | 1,046 | 34% |
| 31–40 | 1,063 | 34% |
| 41–50 | 375 | 12% |
| 51–76 | 192 | 6% |
| Gender | ||
| Cisgender man | 2,941 | 94% |
| Transgender woman | 111 | 4% |
| Cisgender woman | 26 | 1% |
| Genderqueer person | 23 | 1% |
| Transgender man | 18 | 1% |
| Sexual Orientation | ||
| Gay | 2,566 | 82% |
| Bisexual | 323 | 10% |
| Other | 136 | 4% |
| Unknown | 96 | 3% |
| Race/Ethnicity | ||
| Asian/Pacific Islander | 253 | 8% |
| Black or African American | 242 | 8% |
| Hispanic/Latino | 954 | 31% |
| Other | 219 | 7% |
| White | 1,353 | 43% |
| Unknown | 100 | 3% |
| Type of insurance at baseline | ||
| Medicaid | 931 | 30% |
| Government PrEP program | 677 | 22% |
| Private | 1,181 | 38% |
| None/out of pocket | 329 | 11% |
| Unknown | 3 | 0% |
| Baseline housing status | ||
| Homeless | 325 | 10% |
| Not homeless | 2,785 | 89% |
| Unknown | 11 | 0.4% |
| Year started PrEP | ||
| 2014 | 50 | 2% |
| 2015 | 411 | 13% |
| 2016 | 1,148 | 37% |
| 2017 | 1,512 | 48% |
a.
No current PrEP Rx at the end of the study period, but returned to the clinic after most recent PrEP Rx ended
b.
No current PrEP Rx at the end of the study period, and did not return to the clinic after most recent PrEP Rx ended